Department of Emergency of The Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
Central Laboratory of The First Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5647. Epub 2024 Apr 26.
Digestive tract cancer is one of the most common types of cancers globally, with ~4.8 million new cases and 3.4 million cancer‑associated deaths in 2018, accounting for 26% of cancer incidence and 35% of cancer‑related deaths worldwide. S100 protein family is involved in regulating cancer cell proliferation, angiogenesis, epithelial‑mesenchymal transition (EMT), metastasis, metabolism and immune microenvironment homeostasis. The critical role of S100 protein family in digestive tract cancer involves complicated mechanisms, such as cancer stemness remodeling, anaerobic glycolysis regulation, tumor‑associated macrophage differentiation and EMT. The present study systematically reviewed published studies on the compositions, function and the underlying molecular mechanisms of the S100 family, as well as guidance for diagnosis, treatment and prognosis of digestive tract cancer. Systematic review of the roles and underlying molecular mechanisms of S100 protein family may provide new insight into exploring potential cancer biomarkers and the optimized therapeutic strategies for digestive tract cancer.
消化道癌症是全球最常见的癌症类型之一,2018 年全球有~480 万例新发病例和 340 万例与癌症相关的死亡病例,占癌症发病率的 26%和与癌症相关的死亡人数的 35%。S100 蛋白家族参与调节癌细胞增殖、血管生成、上皮-间充质转化(EMT)、转移、代谢和免疫微环境稳态。S100 蛋白家族在消化道癌症中的关键作用涉及复杂的机制,如癌症干细胞重塑、无氧糖酵解调节、肿瘤相关巨噬细胞分化和 EMT。本研究系统地综述了已发表的关于 S100 家族组成、功能及其潜在分子机制的研究,以及对消化道癌症的诊断、治疗和预后的指导。对 S100 蛋白家族的作用及其潜在分子机制的系统研究可能为探索潜在的癌症生物标志物和优化消化道癌症的治疗策略提供新的见解。